Skip to content

Author

Jing Wu

We have 1 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A ketogenic enzyme HMGCS2 drives malignant progression in HER2-negative breast cancer via RAB23-mediated β-catenin/TCF signaling and mediates Apatinib resistance.

BACKGROUND 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) is the rate-limiting enzyme of ketogenesis. However, its role in breast cancer progression and drug resistance beyond metabolic regulation remains poorly understood. This study investigates the oncogenic function and resistance-promoting mechanism of HMGCS2...

Jing Wu, Mei Liu, Wei Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.